Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells (Q36350025)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells (English)

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

P D Greenberg

1

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

D E Kern

2

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

M A Cheever

3

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

language of work or name

0 references

publication date

1 May 1985

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Journal of Experimental Medicine

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

161

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

5

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

1122-1134

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Protection against syngeneic lymphoma by a long-lived cytotoxic T-cell clone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Subversion of immune system by tumor cells and role of prostaglandins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Role of different T cells sets in the rejection of syngeneic chemically induced tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

T cell growth factor: parameters of production and a quantitative microassay for activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Discrimination of suppressor T cells of humoral and cell-mediated immunity by anti-Ly and anti-Ia sera

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Characterization of Ia8 antigen, thy-1.2 antigen, complement receptors, and virus production in a group of murine virus-induced leukemia cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Tumor neutralization, immunotherapy, and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro: II. Comparison of cells cultured with and without tumor to noncultured immune cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

30 September 2017

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

29 June 2018

Antigen-reactive cloned helper T cells. I. Unresponsiveness to antigenic restimulation develops after stimulation of cloned helper T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

29 June 2018

A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

22 September 2018

Generation of cytolytic T lymphocytes in thymectomized, irradiated, and bone marrow-reconstituted mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

22 September 2018

Differential effects of cyclophosphamide on the B and T cell compartments of adult mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2187611

22 September 2018

T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of adoptive chemoimmunotherapy of established syngeneic tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of early and delayed antitumor effects following curative adoptive chemoimmunotherapy of established leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

H-2 restriction of adoptive immunotherapy of advanced tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal migration of T lymphocyte clones

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of Ia and H-2 antigens on a macrophage cell line by immune interferon

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Studies on chemically induced rat tumors. II. Partial protection against syngeneic lethal tumors by cloned syngeneic cytotoxic T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of disseminated leukemia with cyclophosphamide and immune cells: tumor immunity reflects long-term persistence of tumor-specific donor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/3921652

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1084/JEM.161.5.1122

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36350025&oldid=1627534370"